SUBSCRIBE
SUBSCRIBE
News   FDA

FDA Clears Potential Johnson & Johnson Blockbuster Arthritis Drug

April 24, 2009 | 
1 min read
AP -- The Food and Drug Administration has approved a potential blockbuster drug from Johnson & Johnson that fights three forms of arthritis caused by immune-system deficiencies.
FDA Approvals
Johnson & Johnson Family of Companies Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Innovation - Think differently - Being different, taking risky, move for success in life -The graphic of rocket also represents the concept of courage, enterprise, confidence, belief, fearless, daring,
Gene therapy
Rocket’s Gene Therapy Wins FDA Greenlight, Clearing Way for Future Products
March 27, 2026
 · 
2 min read
 · 
Tristan Manalac
Silhouette of a business person on the top of a mountain peak in sunset background. Winner and conquer of businessman concept.
Approvals
Denali Delivers ‘Welcome Positive’ for Rare Disease Space With FDA’s Hunter Syndrome Nod
March 26, 2026
 · 
3 min read
 · 
Tristan Manalac
Adults hand drawing pathway for baby boy. Parent influence on child development and future. Parental control and support for growth and education of kid. vector
FDA
Rezolute Lauds ‘Unusual’ FDA Feedback Supportive of Path Forward for Hypoglycemia Drug
March 24, 2026
 · 
3 min read
 · 
Heather McKenzie
Focal seizure. Vector illustration of human brain and electroencephalograhy or EEG originating from temporal lobe.
Parkinson’s disease
FDA Warns of Seizure Risk With Some Parkinson’s Drugs
March 23, 2026
 · 
2 min read
 · 
Tristan Manalac